Package Leaflet: Information for the Patient
Brivaracetam Teva 10 mg Film-Coated Tablets EFG
Brivaracetam Teva 25 mg Film-Coated Tablets EFG
Brivaracetam Teva 50 mg Film-Coated Tablets EFG
Brivaracetam Teva 75 mg Film-Coated Tablets EFG
Brivaracetam Teva 100 mg Film-Coated Tablets EFG
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
Contents of the pack
What is Brivaracetam Teva
Brivaracetam Teva contains the active substance brivaracetam. It belongs to a group of medicines called “antiepileptics”. These medicines are used to treat epilepsy.
What is Brivaracetam Teva used for
Do not take Brivaracetam Teva
Severe skin reactions, including Stevens-Johnson syndrome, have been reported with brivaracetam treatment. Do not take this medicine and contact your doctor immediately if you notice any of the symptoms related to these severe skin reactions described in section 4.
Warnings and precautions
Consult your doctor or pharmacist before starting to take brivaracetam if:
Children
Brivaracetam is not recommended for use in children under 2 years of age.
Other medicines and Brivaracetam Teva
Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines.
In particular, tell your doctor if you are taking any of the following medicines, as your doctor may need to adjust your dose of brivaracetam:
Taking Brivaracetam Teva with alcohol
Pregnancy and breastfeeding
Women of childbearing age should discuss the use of contraceptives with their doctor.
If you are pregnant or breastfeeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.
It is not recommended to take brivaracetam if you are pregnant, as the effects of brivaracetam on pregnancy and the fetus are unknown.
It is not recommended to breastfeed your baby while taking this medicine, as brivaracetam is excreted in breast milk.
Do not stop treatment without consulting your doctor first. Stopping treatment could increase the number of seizures you have and harm your baby.
Driving and using machines
Brivaracetam Teva contains lactose and sodium
If your doctor has told you that you have an intolerance to some sugars, consult with them before taking this medicine.
This medicine contains less than 1 mmol of sodium (23 mg) per tablet; this is essentially “sodium-free”.
Follow exactly the administration instructions of this medicine given by your doctor. If you are not sure, consult your doctor or pharmacist again.
You will take Brivaracetam Teva together with other medicines to treat epilepsy.
Dose
Your doctor will calculate the correct daily dose for you. Take the daily dose divided into two equal doses, approximately 12 hours apart.
Adolescents and children weighing 50 kg or more, and adults
Adolescents and children weighing between 20 kg and less than 50 kg
Children weighing between 10 kg and less than 20 kg
Patient with liver problems
If you have liver problems:
How to take the tablets of Brivaracetam Teva
Duration of treatment
Brivaracetam is a long-term treatment – continue taking this medicine until your doctor tells you to stop.
If you take more Brivaracetam Teva than you should
If you take more Brivaracetam Teva than you should, consult your doctor. You may feel dizzy and drowsy.
You may also experience any of the following symptoms: feeling unwell, feeling like you are spinning, problems keeping your balance, anxiety, feeling very tired, irritability, aggression, difficulty sleeping, depression, thoughts or attempts to harm yourself or suicide.
If you forget to take Brivaracetam Teva
If you stop taking Brivaracetam Teva
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Very common:may affect more than 1 in 10 people.
Common:may affect up to 1 in 10 people.
Uncommon:may affect up to 1 in 100 people
Frequency not known:cannot be estimated from the available data
Other side effects in children
Common:may affect up to 1 in 10 people.
Reporting of side effects
If you experience any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Spanish Medicines Agency's website: https://www.notificaram.es. By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the carton and blister after “EXP”. The expiry date refers to the last day of that month.
This medicine does not require any special storage conditions.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help to protect the environment.
Composition of Brivaracetam Teva
The active substance is brivaracetam.
Each film-coated tablet of Brivaracetam Teva 10 mg contains 10 mg of brivaracetam.
Each film-coated tablet of Brivaracetam Teva 25 mg contains 25 mg of brivaracetam.
Each film-coated tablet of Brivaracetam Teva 50 mg contains 50 mg of brivaracetam.
Each film-coated tablet of Brivaracetam Teva 75 mg contains 75 mg of brivaracetam.
Each film-coated tablet of Brivaracetam Teva 100 mg contains 100 mg of brivaracetam.
The other ingredients (excipients) are:
Core of the tablet:
Croscarmellose sodium, lactose and magnesium stearate.
Coating of the tablet:
Appearance of the product and contents of the pack
Brivaracetam Teva 10 mg are film-coated tablets, white to off-white, round, 4.9 mm in diameter and engraved on one side with “10” and “TV” on the other.
Brivaracetam Teva 25 mg are film-coated tablets, light grey to grey, oval, 8.8 mm x 4.9 mm and engraved on one side with “25” and “TV” on the other.
Brivaracetam Teva 50 mg are film-coated tablets, light yellow to yellow, oval, 11.6 mm x 6.5 mm and engraved on one side with “50” and “TV” on the other.
Brivaracetam Teva 75 mg are film-coated tablets, light purple to purple, oval, 12.9 mm x 7.2 mm and engraved on one side with “75” and “TV” on the other.
Brivaracetam Teva 100 mg are film-coated tablets, light greenish grey to greenish grey, oval, 14.4 mm x 8 mm and engraved on one side with “100” and “TV” on the other.
Brivaracetam Teva is available in packs containing 14, 56 and 168 tablets in transparent PVC/Aclar/PVC-Aluminium blisters.
Brivaracetam Teva is available in unit dose packs containing 14x1, 56x1 and 168x1 tablets in transparent PVC/Aclar/PVC-Aluminium blisters.
Brivaracetam Teva is available in HDPE bottles with desiccant and child-resistant PP caps containing 100 tablets.
Not all pack sizes may be marketed.
Marketing authorisation holder and manufacturer
Marketing authorisation holder:
Teva B.V.
Swensweg 5,
2031GA Haarlem,
Netherlands
Manufacturer:
Actavis Ltd
BLB015-016, Bulebel Industrial Estate
Zejtun, ZTN 3000
Malta
or
Teva Operations Poland Sp. z.o.o,
ul. Mogilska 80.
31-546, Krakow
Poland
You can request more information about this medicine from the local representative of the marketing authorisation holder:
Teva Pharma, S.L.U.
C/ Anabel Segura, 11 Edificio Albatros B, 1ª planta
28108 Alcobendas (Madrid)
Spain
This medicine is authorised in the Member States of the European Economic Areaunder the following names:
Belgium, Czech Republic, Denmark, Spain, Italy, Poland, Sweden, Finland, Hungary and Netherlands: | Brivaracetam Teva |
France: | BRIVARACETAM TEVA |
Germany, Luxembourg: | Brivaracetam-ratiopharm |
Date of last revision of this leaflet:March 2025
Detailed information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http: //www.aemps.gob.es/
You can access detailed and up-to-date information about this medicine by scanning the QR code included in the packaging with your smartphone. You can also access this information at the following internet address: https://cima.aemps.es/cima/dochtml/p/XXXXX/P_XXXXX.html